325 related articles for article (PubMed ID: 32213586)
21. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
22. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus.
Lee H; Veazey R; Williams K; Li M; Guo J; Neipel F; Fleckenstein B; Lackner A; Desrosiers RC; Jung JU
Nat Med; 1998 Apr; 4(4):435-40. PubMed ID: 9546789
[TBL] [Abstract][Full Text] [Related]
23. Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells.
Elia I; Broekaert D; Christen S; Boon R; Radaelli E; Orth MF; Verfaillie C; Grünewald TGP; Fendt SM
Nat Commun; 2017 May; 8():15267. PubMed ID: 28492237
[TBL] [Abstract][Full Text] [Related]
24. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
25. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
26. Initiation of angiogenic Kaposi's sarcoma lesions.
Hayward GS
Cancer Cell; 2003 Jan; 3(1):1-3. PubMed ID: 12559168
[TBL] [Abstract][Full Text] [Related]
27. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
28. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
29. Proline dehydrogenase (oxidase) in cancer.
Liu W; Phang JM
Biofactors; 2012; 38(6):398-406. PubMed ID: 22886911
[TBL] [Abstract][Full Text] [Related]
30. Hijacking of nucleotide biosynthesis and deamidation-mediated glycolysis by an oncogenic herpesvirus.
Wan Q; Tavakoli L; Wang TY; Tucker AJ; Zhou R; Liu Q; Feng S; Choi D; He Z; Gack MU; Zhao J
Nat Commun; 2024 Feb; 15(1):1442. PubMed ID: 38365882
[TBL] [Abstract][Full Text] [Related]
31. CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells.
Dai L; Trillo-Tinoco J; Chen Y; Bonstaff K; Del Valle L; Parsons C; Ochoa AC; Zabaleta J; Toole BP; Qin Z
Oncotarget; 2016 Jan; 7(4):3806-18. PubMed ID: 26675551
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
[TBL] [Abstract][Full Text] [Related]
33. Molecular piracy of Kaposi's sarcoma associated herpesvirus.
Choi J; Means RE; Damania B; Jung JU
Cytokine Growth Factor Rev; 2001; 12(2-3):245-57. PubMed ID: 11325605
[TBL] [Abstract][Full Text] [Related]
34. Cellular and viral oncogenes: the key to unlocking unknowns of Kaposi's sarcoma-associated herpesvirus pathogenesis.
Hussein HAM; Okafor IB; Walker LR; Abdel-Raouf UM; Akula SM
Arch Virol; 2018 Oct; 163(10):2633-2643. PubMed ID: 29936609
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
36. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.
Cesarman E; Nador RG; Bai F; Bohenzky RA; Russo JJ; Moore PS; Chang Y; Knowles DM
J Virol; 1996 Nov; 70(11):8218-23. PubMed ID: 8892957
[TBL] [Abstract][Full Text] [Related]
38. Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.
Sousa-Squiavinato AC; Silvestre RN; Elgui De Oliveira D
Rev Med Virol; 2015 Sep; 25(5):273-85. PubMed ID: 26192396
[TBL] [Abstract][Full Text] [Related]
39. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM.
Tadmor H; Greenway M; Ahuja A; Orgil O; Liao G; Ambinder RF; Hayward SD; Shamay M
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
